TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Aloin, Irinotecan
Phytochemical Name Aloin (PubChem CID: 12305761 )
Anticancer drug Name Irinotecan (PubChem CID: 60838 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 761
Pair Name Aloin, Irinotecan
Disease Info [ICD-11: 2B91] Colorectal cancer Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Down-regulation Phosphorylation AKT1 hsa207
Up-regulation Cleavage CASP3 hsa836
Up-regulation Cleavage CASP9 hsa842
Down-regulation Expression IGF1R hsa3480
Down-regulation Phosphorylation MTOR hsa2475
Up-regulation Cleavage PARP1 hsa142
Down-regulation Phosphorylation PIK3CA hsa5290
In Vitro Model LoVo Colon adenocarcinoma Homo sapiens (Human) CVCL_0399
In Vivo Model 4×10⁶ LoVo cells were suspended in serum-free Matrigel medium.Control (DMSO), CPT-11(2 mg/Kg), Aloin (20 mg/Kg), and combination (2 mg/Kg CPT-11 + 20 mg/Kg Aloin). The mice were treated via intratumor injection, every 48 h for four weeks.
Result Our findings suggests that CPT-11 and Aloin are potential combination treatment partners against colorectal cancer. MicroRNA-133b may serve as a co-therapeutic target with IGF1R against colorectal cancer, which might overcome the existing treatment limitations.
03. Reference
No. Title Href
1 Aloin and CPT-11 combination activates miRNA-133b and downregulates IGF1R- PI3K/AKT/mTOR and MEK/ERK pathways to inhibit colorectal cancer progression. Biomed Pharmacother. 2023 Dec 31;169:115911. doi: 10.1016/j.biopha.2023.115911. Click
It has been 46680 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP